Schweitzer J B, Smith R M, Jarett L
Proc Natl Acad Sci U S A. 1980 Aug;77(8):4692-6. doi: 10.1073/pnas.77.8.4692.
Binding of 125I-labeled insulin to rat liver and adipocyte plasma membranes has been investigated after treatment of the membranes with agents that modify disulfide bonds or sulfhydryl groups. Dithiothreitol, a disulfide-reducing agent, produced a bimodal response in adipocyte plasma membranes with dose-dependent increases in binding occurring over the range of 0-1 mM dithiothreitol; 5 mM dithiothreitol produced decreased binding. Insulin binding reached its maximal increase at 1 mM and was 3 times control values. Scatchard analysis of the 1 mM dithiothreitol effect revealed a straight line plot indicative of one class of sites with a Ka of 1.0 x 10(8) M-1 which is intermediate between the two Kas obtained from the curvilinear Scatchard plot of control membranes. There was a 20-fold increase in the number of intermediate-affinity receptors compared to high-affinity receptors. The increased 125I-labeled insulin binding after dithiothreitol treatment was reversed by oxidized glutathione in a dose-dependent manner. Interposition of treatment with N-ethylmaleimide, an alkylating agent, prevented oxidized glutathione from reversing the dithiothreitol effect. Reduced glutathione produced the same effect as dithiothreitol. Liver plasma membranes treated with up to 1 mM dithiothreitol exhibited a maximum increase in insulin binding of 20% compared to control. Dithiothreitol at 5 mM decreased insulin binding below that of control membranes. The results indicate that the dithiothreitol effect on insulin binding to adipocyte plasma membranes is due to disruption of disulfide bonds, and that the structural organization of the insulin receptor on the plasma membranes is different for liver and for adipose tissue. The data imply that the insulin receptors on the plasma membrane of adipocytes possess at least two functionally distinct subclasses of disulfide bond but liver insulin receptors do not.
在用能修饰二硫键或巯基的试剂处理大鼠肝脏和脂肪细胞质膜后,对125I标记胰岛素与这些质膜的结合情况进行了研究。二硫苏糖醇是一种二硫键还原剂,它在脂肪细胞质膜上产生了双峰反应,在0至1 mM二硫苏糖醇范围内,结合呈剂量依赖性增加;5 mM二硫苏糖醇则使结合减少。胰岛素结合在1 mM时达到最大增加,为对照值的3倍。对1 mM二硫苏糖醇作用的Scatchard分析显示为一条直线图,表明存在一类位点,其解离常数(Ka)为1.0×10(8) M-1,介于从对照膜的曲线Scatchard图获得的两个Ka值之间。与高亲和力受体相比,中等亲和力受体的数量增加了20倍。二硫苏糖醇处理后125I标记胰岛素结合的增加可被氧化型谷胱甘肽以剂量依赖性方式逆转。用烷基化剂N-乙基马来酰亚胺进行预处理可阻止氧化型谷胱甘肽逆转二硫苏糖醇的作用。还原型谷胱甘肽产生了与二硫苏糖醇相同的效果。用高达1 mM二硫苏糖醇处理的肝脏质膜与对照相比,胰岛素结合的最大增加为20%。5 mM二硫苏糖醇使胰岛素结合低于对照膜。结果表明,二硫苏糖醇对胰岛素与脂肪细胞质膜结合的作用是由于二硫键的破坏,并且质膜上胰岛素受体的结构组织在肝脏和脂肪组织中是不同的。数据表明,脂肪细胞质膜上的胰岛素受体至少拥有两个功能不同的二硫键亚类,而肝脏胰岛素受体则没有。